Fluorescence tomography quantifies tumor response to chemotherapy

Article

CONTEXT: To more precisely gauge tumor reaction to chemotherapy in small animals, researchers at the Center for Molecular Imaging Research at Massachusetts General Hospital, Harvard Medical School are investigating the effectiveness of fluorescence molecular tomography (FMT) compared with the more commonly used planar illumination. In a study led by Dr. Vasilis Ntziachristos, an assistant professor of bioengineering, in vivo imaging using 3D FMT demonstrated superior quantification, resolution, and more accurate depth and size information than 2D planar imaging.

RESULTS: Thirteen mice were injected in the left mammary pad with Lewis lung carcinoma (LLC) cells and then with cyclophosphamide-resistant LLC cells in the right mammary pad. Eight days later, 10 animals received an injection of cyclophosphamide. To obtain fluorescent images, mice were injected with Annexin V tagged with a cyanine dye (Cy5.5-Annexin V), a phosphatidylserine-sensing fluorescent probe. Two hours after the probe injection, animals were imaged on a prototype scanner combining planar imaging and FMT. Imaging revealed that fluorochrome concentration increased 10-fold in cyclophosphamide-sensitive tumors and seven-fold in resistant tumors, compared with control groups. While FMT showed consistent quantitative results, planar imaging results varied. FMT was less sensitive than planar imaging to background fluctuations and corrected for attenuation changes as a function of depth.

IMAGE: A planar image (above) corresponds with an FMT slice of a tumor demonstrating uptake of the Annexin V-tagged agents at a depth of 1.3 cm. Uptake patterns from the 0.8-mm slices offer quantitative measures of response to cyclophosphaide therapy. (Image reprinted with permission of Proceedings of National Academy of Sciences)

IMPLICATIONS: FMT has proven very accurate for noninvasive imaging of molecular processes in vivo.

"This optical technology is essential for biomedical research involving small animals and has potential for clinical transferability as well," Ntziachristos said.

The researchers are evaluating ways to further enhance FMT imaging performance by refining their understanding of the physical principles that make FMT possible and developing better hardware to more fully exploit its imaging potential.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.